A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 95 shares of FATE stock, worth $170. This represents 0.0% of its overall portfolio holdings.

Number of Shares
95
Previous 95 -0.0%
Holding current value
$170
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$3.54 - $8.35 $336 - $793
95 New
95 $697,000
Q4 2021

Aug 30, 2024

SELL
$47.84 - $64.34 $1,530 - $2,058
-32 Reduced 33.68%
63 $3.69 Million

Others Institutions Holding FATE

About FATE THERAPEUTICS INC


  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $174M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.